📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study. (2015)

First Author: Huizinga TW

Attributed to: Infrastructure for collaboration: Leeds MRC Medical Bioinformatics Centre funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/annrheumdis-2014-205752

PubMed Identifier: 25169728

Publication URI: http://europepmc.org/abstract/MED/25169728

Type: Journal Article/Review

Volume: 74

Parent Publication: Annals of the rheumatic diseases

Issue: 1

ISSN: 0003-4967